nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—SLC16A1—Valproic Acid—migraine	0.463	0.552	CbGbCtD
Niflumic Acid—UGT1A9—Valproic Acid—migraine	0.266	0.317	CbGbCtD
Niflumic Acid—PTGS1—Valproic Acid—migraine	0.111	0.132	CbGbCtD
Niflumic Acid—CLCNKA—Stimuli-sensing channels—TRPM8—migraine	0.0161	0.171	CbGpPWpGaD
Niflumic Acid—CLCNKA—Ion channel transport—TRPM8—migraine	0.0105	0.112	CbGpPWpGaD
Niflumic Acid—CLCNKA—Ion channel transport—ATP1A3—migraine	0.00795	0.0846	CbGpPWpGaD
Niflumic Acid—CLCNKA—Ion channel transport—ATP1A2—migraine	0.00795	0.0846	CbGpPWpGaD
Niflumic Acid—CLCNKA—Ion channel transport—HTR3A—migraine	0.00676	0.072	CbGpPWpGaD
Niflumic Acid—PLA2G1B—blood vessel—migraine	0.0066	0.105	CbGeAlD
Niflumic Acid—CLCNKA—head—migraine	0.00504	0.0805	CbGeAlD
Niflumic Acid—CLCNKA—cerebellum—migraine	0.0045	0.0718	CbGeAlD
Niflumic Acid—CLCNKA—Transmembrane transport of small molecules—TRPM8—migraine	0.00365	0.0389	CbGpPWpGaD
Niflumic Acid—SLC16A7—trigeminal ganglion—migraine	0.00343	0.0548	CbGeAlD
Niflumic Acid—PLA2G4A—Pindolol—Propranolol—migraine	0.0034	1	CbGdCrCtD
Niflumic Acid—PLA2G4A—p38 MAPK Signaling Pathway—MEF2D—migraine	0.00335	0.0357	CbGpPWpGaD
Niflumic Acid—PLA2G1B—cardiovascular system—migraine	0.00294	0.047	CbGeAlD
Niflumic Acid—CLCNKA—Transmembrane transport of small molecules—ATP1A2—migraine	0.00277	0.0295	CbGpPWpGaD
Niflumic Acid—CLCNKA—Transmembrane transport of small molecules—ATP1A3—migraine	0.00277	0.0295	CbGpPWpGaD
Niflumic Acid—PLA2G4A—trigeminal ganglion—migraine	0.00248	0.0396	CbGeAlD
Niflumic Acid—SLC16A7—cardiovascular system—migraine	0.00248	0.0396	CbGeAlD
Niflumic Acid—CLCNKA—Transmembrane transport of small molecules—HTR3A—migraine	0.00235	0.025	CbGpPWpGaD
Niflumic Acid—PLA2G1B—head—migraine	0.00199	0.0318	CbGeAlD
Niflumic Acid—PLA2G1B—nervous system—migraine	0.00189	0.0302	CbGeAlD
Niflumic Acid—PLA2G1B—central nervous system—migraine	0.00182	0.029	CbGeAlD
Niflumic Acid—PLA2G4A—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.00181	0.0193	CbGpPWpGaD
Niflumic Acid—PLA2G4A—cardiovascular system—migraine	0.00179	0.0286	CbGeAlD
Niflumic Acid—SLC16A7—Transmembrane transport of small molecules—TRPM8—migraine	0.00171	0.0182	CbGpPWpGaD
Niflumic Acid—SLC16A7—head—migraine	0.00168	0.0268	CbGeAlD
Niflumic Acid—SLC16A7—nervous system—migraine	0.00159	0.0254	CbGeAlD
Niflumic Acid—PTGS1—blood vessel—migraine	0.00159	0.0253	CbGeAlD
Niflumic Acid—SLC16A1—cardiovascular system—migraine	0.00158	0.0252	CbGeAlD
Niflumic Acid—SLC16A7—central nervous system—migraine	0.00153	0.0245	CbGeAlD
Niflumic Acid—PTGS2—blood vessel—migraine	0.00152	0.0242	CbGeAlD
Niflumic Acid—SLC16A7—cerebellum—migraine	0.0015	0.0239	CbGeAlD
Niflumic Acid—PLA2G1B—brain—migraine	0.00144	0.0231	CbGeAlD
Niflumic Acid—SLC16A7—Transmembrane transport of small molecules—ATP1A2—migraine	0.0013	0.0138	CbGpPWpGaD
Niflumic Acid—SLC16A7—Transmembrane transport of small molecules—ATP1A3—migraine	0.0013	0.0138	CbGpPWpGaD
Niflumic Acid—PTGS1—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.00122	0.013	CbGpPWpGaD
Niflumic Acid—SLC16A7—brain—migraine	0.00122	0.0194	CbGeAlD
Niflumic Acid—PLA2G4A—nervous system—migraine	0.00115	0.0184	CbGeAlD
Niflumic Acid—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—FOS—migraine	0.00114	0.0121	CbGpPWpGaD
Niflumic Acid—PLA2G4A—central nervous system—migraine	0.00111	0.0177	CbGeAlD
Niflumic Acid—SLC16A7—Transmembrane transport of small molecules—HTR3A—migraine	0.0011	0.0117	CbGpPWpGaD
Niflumic Acid—SLC16A1—head—migraine	0.00107	0.0171	CbGeAlD
Niflumic Acid—SLC16A1—nervous system—migraine	0.00101	0.0162	CbGeAlD
Niflumic Acid—PLA2G4A—Endothelins—EDNRA—migraine	0.000999	0.0106	CbGpPWpGaD
Niflumic Acid—SLC16A1—central nervous system—migraine	0.000975	0.0156	CbGeAlD
Niflumic Acid—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.00097	0.0103	CbGpPWpGaD
Niflumic Acid—SLC16A1—cerebellum—migraine	0.000953	0.0152	CbGeAlD
Niflumic Acid—PTGS2—trigeminal ganglion—migraine	0.000937	0.015	CbGeAlD
Niflumic Acid—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—ESR1—migraine	0.000895	0.00953	CbGpPWpGaD
Niflumic Acid—PLA2G4A—brain—migraine	0.000879	0.014	CbGeAlD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—LRP1—migraine	0.000863	0.00918	CbGpPWpGaD
Niflumic Acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.000809	0.00861	CbGpPWpGaD
Niflumic Acid—SLC16A1—brain—migraine	0.000774	0.0124	CbGeAlD
Niflumic Acid—PLA2G4A—PDGF Pathway—FOS—migraine	0.00074	0.00787	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—TRPM8—migraine	0.00073	0.00777	CbGpPWpGaD
Niflumic Acid—PTGS1—cardiovascular system—migraine	0.000708	0.0113	CbGeAlD
Niflumic Acid—PTGS2—cardiovascular system—migraine	0.000676	0.0108	CbGeAlD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000553	0.00589	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000553	0.00589	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—FOS—migraine	0.000517	0.0055	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Endothelins—FOS—migraine	0.000504	0.00536	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOS—migraine	0.000503	0.00535	CbGpPWpGaD
Niflumic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—migraine	0.00048	0.00511	CbGpPWpGaD
Niflumic Acid—PTGS1—head—migraine	0.000479	0.00765	CbGeAlD
Niflumic Acid—PTGS1—Overview of nanoparticle effects—TNF—migraine	0.000478	0.00508	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—HTR3A—migraine	0.00047	0.005	CbGpPWpGaD
Niflumic Acid—PTGS2—head—migraine	0.000458	0.00731	CbGeAlD
Niflumic Acid—PTGS1—nervous system—migraine	0.000454	0.00726	CbGeAlD
Niflumic Acid—PTGS1—central nervous system—migraine	0.000437	0.00699	CbGeAlD
Niflumic Acid—UGT1A9—NRF2 pathway—SLC6A4—migraine	0.000435	0.00462	CbGpPWpGaD
Niflumic Acid—PTGS2—nervous system—migraine	0.000434	0.00694	CbGeAlD
Niflumic Acid—PTGS2—central nervous system—migraine	0.000418	0.00668	CbGeAlD
Niflumic Acid—PTGS2—cerebellum—migraine	0.000409	0.00653	CbGeAlD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000386	0.0041	CbGpPWpGaD
Niflumic Acid—PTGS2—Overview of nanoparticle effects—TNF—migraine	0.000379	0.00403	CbGpPWpGaD
Niflumic Acid—PTGS1—brain—migraine	0.000347	0.00555	CbGeAlD
Niflumic Acid—PTGS2—brain—migraine	0.000332	0.0053	CbGeAlD
Niflumic Acid—UGT1A9—NRF2 pathway—TGFBR2—migraine	0.000328	0.00349	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—MTHFR—migraine	0.000325	0.00346	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—migraine	0.000325	0.00346	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CACNA1A—migraine	0.00032	0.00341	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000307	0.00327	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—FOS—migraine	0.000291	0.0031	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000289	0.00307	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—RAMP1—migraine	0.000272	0.0029	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CALCRL—migraine	0.000272	0.0029	CbGpPWpGaD
Niflumic Acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.000261	0.00277	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—MTHFR—migraine	0.000258	0.00275	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—BDNF—migraine	0.000242	0.00258	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.00023	0.00245	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR1D—migraine	0.000198	0.0021	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CACNA1A—migraine	0.000187	0.00199	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—migraine	0.000187	0.00199	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR2B—migraine	0.000184	0.00196	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—migraine	0.000175	0.00186	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000165	0.00175	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—FOS—migraine	0.000164	0.00174	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CALCRL—migraine	0.000161	0.00171	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RAMP1—migraine	0.000161	0.00171	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CACNA1A—migraine	0.000146	0.00155	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—TNF—migraine	0.00014	0.00149	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000124	0.00131	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CACNA1A—migraine	0.000121	0.00128	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR1B—migraine	0.00012	0.00127	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR1D—migraine	0.000117	0.00124	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR1A—migraine	0.000115	0.00123	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—TAC1—migraine	0.000114	0.00121	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—NPS—migraine	0.000114	0.00121	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.000112	0.00119	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR2C—migraine	0.000111	0.00118	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—TNF—migraine	0.000111	0.00118	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR2B—migraine	0.000109	0.00116	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—EDNRA—migraine	0.000108	0.00115	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—MTHFR—migraine	0.000106	0.00113	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CALCA—migraine	0.000104	0.00111	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CACNA1A—migraine	9.84e-05	0.00105	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR7—migraine	9.75e-05	0.00104	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LRP1—migraine	9.56e-05	0.00102	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TNF—migraine	8.8e-05	0.000936	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CACNA1A—migraine	7.81e-05	0.000831	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOTCH4—migraine	7.33e-05	0.00078	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—LRP1—migraine	7.32e-05	0.000779	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR1B—migraine	7.08e-05	0.000753	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR2A—migraine	6.83e-05	0.000727	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR1A—migraine	6.81e-05	0.000725	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NPS—migraine	6.71e-05	0.000714	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TAC1—migraine	6.71e-05	0.000714	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PGR—migraine	6.71e-05	0.000714	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR2C—migraine	6.58e-05	0.0007	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EDNRA—migraine	6.4e-05	0.000681	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOTCH3—migraine	6.24e-05	0.000664	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MTHFR—migraine	6.2e-05	0.000659	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CALCA—migraine	6.16e-05	0.000655	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—migraine	5.98e-05	0.000637	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR7—migraine	5.76e-05	0.000613	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TGFBR2—migraine	4.96e-05	0.000528	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MTHFR—migraine	4.82e-05	0.000513	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CALCA—migraine	4.72e-05	0.000502	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR2A—migraine	4.04e-05	0.000429	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MTHFR—migraine	3.99e-05	0.000425	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFBR2—migraine	3.8e-05	0.000404	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ESR1—migraine	3.58e-05	0.000381	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MTHFR—migraine	3.26e-05	0.000346	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTHFR—migraine	3.09e-05	0.000328	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTHFR—migraine	2.58e-05	0.000275	CbGpPWpGaD
